Craig R Fairchild Selected Research

Pharmaceutical Preparations

1/2009	Preclinical efficacy spectrum and pharmacokinetics of ixabepilone.
12/2008	Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
4/2005	Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Craig R Fairchild Research Topics

Disease

15	Neoplasms (Cancer) 12/2010 - 03/2002
3	Breast Neoplasms (Breast Cancer) 01/2009 - 12/2008
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2007 - 05/2004
1	Malaria 10/2010
1	Ovarian Neoplasms (Ovarian Cancer) 01/2010
1	Colonic Neoplasms (Colon Cancer) 01/2009
1	Neoplasm Metastasis (Metastasis) 12/2008
1	Kidney Neoplasms (Kidney Cancer) 12/2008
1	Lymphoid Leukemia 06/2007
1	Lewis Lung Carcinoma 04/2005
1	Leukemia 05/2004
1	Carcinoma (Carcinomatosis) 03/2004

Drug/Important Bio-Agent (IBA)

3	Antineoplastic Agents (Antineoplastics)IBA 01/2010 - 12/2008
3	ixabepilone (BMS 247550)FDA Link 01/2009 - 12/2008
3	Pharmaceutical PreparationsIBA 01/2009 - 04/2005
2	GlycosidesIBA 12/2010 - 06/2007
2	MacrolidesIBA 02/2010 - 12/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2009 - 12/2008
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2009 - 12/2008
2	Epothilones (Epothilone)IBA 12/2008 - 12/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 07/2006 - 04/2005
2	carbazoleIBA 04/2005 - 03/2004
1	SterolsIBA 12/2010
1	KetonesIBA 12/2010
1	tocopherylquinoneIBA 10/2010
1	Antimalarials (Antimalarial Agents)IBA 10/2010
1	Benzoates (Benzoate)IBA 02/2010
1	DiterpenesIBA 02/2010
1	AcidsIBA 01/2010
1	SesquiterpenesIBA 01/2010
1	HydroquinonesIBA 01/2010
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2009
1	BMS 536924IBA 01/2009
1	Tyrosine Kinase InhibitorsIBA 01/2009
1	epothilone B (EPO906)IBA 01/2009
1	Sunitinib (Sutent)FDA Link 12/2008
1	Bevacizumab (Avastin)FDA Link 12/2008
1	Angiogenesis InhibitorsIBA 12/2008
1	Taxoids (Taxanes)IBA 12/2008
1	TubulinIBA 12/2008
1	AnthracyclinesIBA 12/2008
1	Capecitabine (Xeloda)FDA Link 12/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2008
1	taxaneIBA 12/2008
1	Biological ProductsIBA 09/2008
1	marmycin AIBA 09/2007
1	alvaradoin EIBA 06/2007
1	chrysophanic acidIBA 06/2007
1	BMS 286309IBA 07/2006
1	BMS 250749IBA 04/2005
1	Farnesyltranstransferase (Farnesyltransferase)IBA 06/2004
1	7- cyano- 2,3,4,5- tetrahydro- 1- (1H- imidazol- 4- ylmethyl)- 3- (phenylmethyl)- 4- (2- thienylsulfonyl)- 1H- 1,4- benzodiazepine (BMS 214662)IBA 06/2004
1	BMS225975IBA 06/2004
1	Cytostatic AgentsIBA 06/2004
1	silvestrolIBA 05/2004
1	episilvestrolIBA 05/2004
1	3,9- difluoro- 12,13- dihydro- 13- (6- aminoglucopyranosyl)- 5H,13H- benzo(b)thienyl(2,3- a)pyrrolo(3,4- c)carbazole- 5,7(6H)- dioneIBA 03/2004
1	Chloroform (Trichloromethane)IBA 06/2003
1	flavoneIBA 06/2003
1	casticinIBA 06/2003
1	Cyclin EIBA 08/2002
1	XanthonesIBA 03/2002
1	vismione BIBA 03/2002

Therapy/Procedure

2	Therapeutics 12/2008 - 12/2008
1	Drug Therapy (Chemotherapy) 12/2008